Business · 23/11/2015
FDA Classifies Prostate Lesion Documentation System into Class II with Special Controls
The FDA has classified the Prostate Lesion Documentation System into Class II, requiring special controls to ensure the device's safety and effectiveness, following a review process.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →